ETFs with exposure to Simulations Plus, Inc. : November 20, 2017 Mon, 20 Nov 2017 18:18:20 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Simulations Plus, Inc. Here are 5 ETFs with the largest exposure to SLP-US. Comparing the performance and risk of Simulations Plus, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
(Read more...)
Simulations Plus, Inc. :SLP-US: Earnings Analysis: Q4, 2017 By the Numbers : November 20, 2017 Mon, 20 Nov 2017 13:22:12 +0000 Categories: Yahoo FinanceGet free summary analysis Simulations Plus, Inc. reports financial results for the quarter ended August 31, 2017. We analyze the earnings along side the following peers of Simulations Plus, Inc. – Authentidate Holding Corp., Quality Systems, Inc., Allscripts Healthcare Solutions, Inc. and Medidata Solutions, Inc. (ADAT-US, QSII-US, MDRX-US and MDSO-US) that have also reported for ... Read more
(Read more...)
Simulations Plus, Inc. :SLP-US: Earnings Analysis: 2017 By the Numbers : November 17, 2017 Fri, 17 Nov 2017 14:54:37 +0000 Categories: Yahoo FinanceGet free summary analysis Simulations Plus, Inc. reports financial results for the year ended August 31, 2017. We analyze the earnings along side the following peers of Simulations Plus, Inc. – Authentidate Holding Corp., Quality Systems, Inc., Allscripts Healthcare Solutions, Inc. and Medidata Solutions, Inc. (ADAT-US, QSII-US, MDRX-US and MDSO-US) that have also reported for ... Read more
(Read more...)
Simulations Plus to Present at LD Micro 10th Annual Main Event on December 6 Thu, 16 Nov 2017 13:30:00 +0000 Simulations Plus, Inc. , a leading provider of software for pharmaceutical discovery and development, today announced that chairman and chief executive officer, Walt Woltosz, will present at the 10th annual LD Micro Main Event at 4 p.m.
Simulations Plus posts 4Q profit Thu, 16 Nov 2017 10:15:08 +0000 The Lancaster, California-based company said it had profit of 6 cents per share. The maker of software used in pharmaceutical research posted revenue of $6.3 million in the period. For the year, the company ...
Simulations Plus Reports FY2017 and Fourth Quarter FY2017 Financial Results Tue, 14 Nov 2017 21:01:00 +0000 Simulations Plus, Inc. , a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2017 fiscal year and fourth quarter ended August 31, 2017.
Simulations Plus Inc. to Host Earnings Call Tue, 14 Nov 2017 14:10:00 +0000 NEW YORK, NY / ACCESSWIRE / November 14, 2017 / Simulations Plus Inc. (NASDAQ: SLP ) will be discussing their earnings results in their Q4 Earnings Call to be held on Tuesday, November 14, 2017, at 4:15 ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.